Vineti

Orchestrating personalized cell & gene therapy treatments for cancers & rare diseases

Principal Product Designer

2016-2022 | San Francisco & remote

#startup, #enterprise, #healthcare, #cell-therapy, #supply-chain, #logistics

---

⊕ Orchestrating personalized cell & gene therapy treatments for cancers & rare diseases

Vineti was founded to solve the key challenges faced by patients, medical providers, pharmaceutical companies, and regulators in the delivery and commercialization of personalized medicine. Over six years, Vineti became the proven clinical-to-commercial platform for cell & gene therapy supply chain management.

Cell & Gene Therapy

Cell & gene therapies (CGT) are biologic drugs manufactured using the cells (blood or tissue) of a patient. They involve some of the most complex workflows in medicine, and require careful tracking across a series of locations.

⊕

Team & role

⊕

Design Manager to Principal Product Designer

From the ground up, I researched, designed, prototyped, expanded and scaled the configurable, cross-channel patient treatment logistics platform. I worked with balanced teams and mentored grew and mentored our design team throughout.

Solution

Vineti built a platform for clinical and commercial cell & gene therapy supply chain management. The Dominos Pizza Tracker™ of cell therapies, if you will.

Impact

Vineti’s platform supported therapies across 26 disease indications, delivering treatments to ~5,000 patients before exit.

• ~5,000 patient treatments delivered
• 16 pharma company customers
• 26 disease indications

Exit

Software acquired by Johnson & Johnson to continue supporting their global commercial therapy rollouts and ongoing clinical trials.

---

Vineti posts

Enterprise & Platforms & Regulation, oh my!

⊕

Groktalk series hosted by Groksmith in Yerevan, Armenia

End-to-end platform patterns

⊕

Context: Extending platform functionality and establishing configurable patterns.
Impact: Expanded coverage to any autologous customer, launched a reusable baseline offering.

Chain of Custody Handoff Patterns

⊕

Design 4 Healthcare lightning talks event at Vineti's offices in San Francisco

Zero to MVP

⊕

Context: Enabling first pharma customer to get FDA approval for commercial scale launch of 72% efficacy leukemia treatment.
Impact: Delivered ~4,000 patient treatments, while establishing the foundation of Vineti's future platform.

Comics translation to cancer treatments, a year in review

⊕

For my work life, 2016 was a year of transitions and contrasts.